First Time Loading...

Der Future Science and Technology Holding Group Co Ltd
SZSE:002631

Watchlist Manager
Der Future Science and Technology Holding Group Co Ltd Logo
Der Future Science and Technology Holding Group Co Ltd
SZSE:002631
Watchlist
Price: 3.94 CNY 4.51% Market Closed
Updated: Jun 8, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

4.6B
-4%
Assets
Growth Rates:
1 Year
+5%
3 Years
+36%
5 Years
+80%
7 Years
+139%
10 Years
+194%
2.8B
-8%
Liabilities
Growth Rates:
1 Year
+9%
3 Years
+73%
5 Years
+210%
7 Years
+499%
10 Years
+929%
1.8B
+2%
Equity
Growth Rates:
1 Year
+1%
3 Years
+2%
5 Years
+9%
7 Years
+23%
10 Years
+39%

Balance Sheet Decomposition
Der Future Science and Technology Holding Group Co Ltd

4.6B
Assets
2.8B
Liabilities
4.6B
Assets
2.8B
Liabilities
Current Assets 3.7B
Cash & Short-Term Investments 2.4B
Receivables 225.8m
Other Current Assets 1.1B
Non-Current Assets 985.8m
Long-Term Investments 367m
PP&E 395.1m
Intangibles 125.8m
Other Non-Current Assets 97.9m
Current Liabilities 2.1B
Accounts Payable 296.5m
Accrued Liabilities 77.9m
Short-Term Debt 736.8m
Other Current Liabilities 956.4m
Non-Current Liabilities 760.4m
Long-Term Debt 746.4m
Other Non-Current Liabilities 14.1m

Balance Sheet
Der Future Science and Technology Holding Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
456
649
350
251
467
1 309
871
900
1 180
1 198
Cash
0
0
0
0
0
0
0
0
1 180
1 198
Cash Equivalents
456
649
350
251
467
1 309
871
900
0
0
Short-Term Investments
422
179
183
418
645
282
629
446
514
1 154
Total Receivables
50
62
64
99
89
108
115
222
249
226
Accounts Receivables
7
38
42
57
50
51
47
176
210
193
Other Receivables
44
24
22
43
40
58
68
46
39
33
Inventory
181
188
260
369
464
621
840
1 153
1 185
970
Other Current Assets
29
41
58
61
82
79
52
68
147
104
Total Current Assets
1 138
1 120
915
1 199
1 747
2 399
2 507
2 789
3 276
3 651
PP&E Net
385
439
427
471
501
528
474
575
477
395
PP&E Gross
385
439
427
471
501
528
474
575
477
395
Accumulated Depreciation
57
92
129
166
213
259
301
382
471
527
Intangible Assets
149
191
200
201
199
206
142
138
132
126
Goodwill
0
0
184
138
89
67
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
26
31
33
Long-Term Investments
0
205
206
219
13
146
224
408
434
367
Other Long-Term Assets
1
6
6
9
23
39
63
58
52
65
Other Assets
0
0
184
138
89
67
0
0
0
0
Total Assets
1 673
N/A
1 961
+17%
1 938
-1%
2 237
+15%
2 572
+15%
3 384
+32%
3 409
+1%
3 994
+17%
4 401
+10%
4 637
+5%
Liabilities
Accounts Payable
56
101
97
146
168
200
184
354
335
297
Accrued Liabilities
12
30
36
48
58
50
66
91
94
78
Short-Term Debt
43
33
24
3
60
72
114
88
372
737
Current Portion of Long-Term Debt
0
0
0
0
0
2
3
31
28
15
Other Current Liabilities
136
142
280
415
527
575
632
824
1 019
942
Total Current Liabilities
248
306
437
613
813
899
999
1 389
1 848
2 068
Long-Term Debt
0
0
0
0
0
551
590
742
737
746
Deferred Income Tax
0
0
2
2
2
3
4
5
7
11
Minority Interest
0
15
32
72
93
85
37
20
8
1
Other Liabilities
0
0
1
5
4
3
2
1
3
3
Total Liabilities
248
N/A
321
+30%
472
+47%
691
+46%
913
+32%
1 541
+69%
1 631
+6%
2 157
+32%
2 604
+21%
2 828
+9%
Equity
Common Stock
325
649
651
651
668
669
666
659
659
659
Retained Earnings
370
530
705
771
862
902
835
893
854
866
Additional Paid In Capital
731
460
111
124
212
238
214
188
188
188
Treasury Stock
0
0
0
0
82
63
34
0
0
0
Other Equity
0
0
0
0
0
97
97
97
97
97
Total Equity
1 425
N/A
1 639
+15%
1 466
-11%
1 546
+5%
1 659
+7%
1 843
+11%
1 778
-4%
1 836
+3%
1 798
-2%
1 809
+1%
Total Liabilities & Equity
1 673
N/A
1 961
+17%
1 938
-1%
2 237
+15%
2 572
+15%
3 384
+32%
3 409
+1%
3 994
+17%
4 401
+10%
4 637
+5%
Shares Outstanding
Common Shares Outstanding
649
649
651
651
651
651
647
659
659
659

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 145,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.